Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
OmniComm Systems, which owns early-phase clinical trial electronic data capture software TrialOne, has nailed a major CRO deal worth $11.7 million.
A collaborative effort has developed a synthetic viral genome for bone cancer research and may prove revolutionary in the battle against cancer overall.
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
Microbiome data is now part of Repositive’s Specialised Data Collections and offers researchers 21,000 data sets from human metagenomic studies.
The FDA has awarded a computational science and bioinformatics contract worth up to $112 million to Engility.
The National Cancer Institute is teaming up with Amazon and Microsoft to work on genomic data platforms.
Veeva Systems is wading into the fight between Medidata and Oracle for the EDC market.
The IT services offshoot of Novo Nordisk has teamed up with SAP to help companies comply with upcoming regulatory changes.
Y Combinator alum Benchling has raised $7 million to advance its cloud electronic lab notebook and CRISPR design software.
The Government Accountability Office has blasted FDA for failing to adequately control access to confidential data.
Merck KGaA has added a fresh batch of startups to its incubator, including firms focused on automating data transfers and facilitating lab equipment sharing.